The Top 10 340B Stories of 2016

by Admin | December 21, 2016 4:00 pm

December 21, 2016—The 340B program mega-guidance was the chief concern of 340B Informed readers for the second year in a row.

In an exact repeat of 2015, four of this year’s 10 most-popular stories were about the guidance, including our top story of 2016. The mega-guidance’s status remains “pending review” at the White House Office of Management and Budget. But with President-elect Trump’s inauguration now just 30 days away, it is unlikely the guidance will be released.

1. OMB Reports on Status of 340B Guidance and Regulations[1]
2. House Republicans Want to Know How EpiPen Scandal Affects 340B[2]
3. Four Big 340B Mega-Guidance Concerns for Hospitals[3]
4. President Seeks Express Rulemaking Power for 340B Program[4]
5. House Appropriators Concerned About 340B Guidance and Ceiling Price Website[5]
6. HRSA Seeing “Great Trends” in 340B Audits[6]
7. Final 340B Mega-Guidance Takes a Step Toward Release[7]
8. CMS Rule Likely Won’t Block Hospitals Using 340B in New Offsite Locations[8]
9. 340B Program Essential, Hospitals Say at Capitol Hill Briefing[9]
10. The 340B Drug Discount Program Explained[10]

---

Register – 340B Coalition Winter Conference – February 1-3, 2017 – San Francisco, Calif.[11]

Source URL: https://340binformed.org/2016/12/the-top-10-340b-stories-of-2016/

---